EUROPEAN JOURNAL OF

PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

ICV - 79.57

Abstract

NON–ST-ELEVATION MYOCARDIAL INFARCTION (NSTEMI) OUTCOMES IN TYPE 2 DIABETIC PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY STENOSIS: DIABETIC MYOCARDIAL INFARCTION CORONARY NON-OBSTRUCTIVE STENOSIS: DIA-MYCONOS STUDY.

Raffaele Marfella, MD, Phd, Celestino Sardu, MD, Msc, PhD*, Maria Luisa Balestrieri, PhD, Mario Siniscalchi, MD, PhD, Antonino Coppola, MD, Fabio Minicucci, MD, Pasquale Paolisso, MD, Davide D’Andrea, MD, Giuseppe Signoriello, MD, Paolo Calabrò, MD, PhD, Pier Francesco Rambaldi, MD, Ciro Mauro, MD, Maria Rosaria Rizzo, MD, PhD and Michelangela Barbieri, MD, PhD

ABSTRACT

Objective: Management of type 2 diabetic patients (DMT2) with non-obstructive coronary stenosis (NOCS) Non–ST-Elevation Myocardial Infarction (NSTEMI) is unclear. We evaluate the 12-month prognosis of DMT2 with NOCS-NSTEMI and compared them with a cohort of DMT2 with NSTEMI and obstructive coronary stenosis (OCS) treated with percutaneous coronary intervention (PCI). Methods: DIAbetic MYocardial COronary Non-Obstructive Stenosis (DIA-MYCONOS) was an observational study prospective study of NSTEMI DMT2 patients undergoing angiographic study. 1098 DMT2 patients with first NSTEMI undergoing coronary angiography were studied. Patients were categorized in two groups, either with or without OCS (stenosis >50%). OCS patients were treated with PCI and optimal medical therapy (n=922, 84%). NOCS patients were treated with optimal medical therapy alone (n=176, 16%). Endpoints included cardiac mortality, all-cause mortality and re-hospitalization for coronary disease and heart failure. Results: OCS-NSTEMI patients were undergoing to PCI plus medical therapy, whereas NOCS-NSTEMI patients were treated with medical therapy. Groups received similar secondary prevention therapies. 1098 patients were followed-up for 1 year. In-hospital mortality was similar (1.11 vs. 1.14%), and 1-year total mortality was 6.72% in NSTEMI patients with OCS treated with PCI and 11.93% in NSTEMI patients with NOCS treated with medical therapy (P<0.09). 18.3% of NSTEMI patients with OCS and 36.9% of NSTEMI patients with NOCS were re-hospitalized for cardiovascular diseases (P <0.05). Conclusions: NOCS-NSTEMI-DMT2 patients treated with medical therapy have poor prognoses as compared with OCS-NSTEMI patients treated with PCI, despite a less aggressive initial atherosclerosis. These findings evidence a possible gap in the NOCS-NSTEMI management.

Keywords: diabetes, myocardial infarction, coronary stenosis.


[Full Text Article] [Download Certificate]

EJMPR Citation Report

  All Since 2021
 Citation  4339  2797
 h-index  23  20
 i10-index  109  52

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2026 issue has been successfully launched on 1 NOVEMBER 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

BEST ARTICLE AWARDS

European Journal of Pharmaceutical and Medical Research is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Prof. Dr. Dhrubo Jyoti Sen
Download Article : Click Here

Google Scholar

Indian Science Publications

InfoBase Index (In Process)

SOCOLAR, China

Research Bible, Fuchu, Tokyo. JAPAN

International Society for Research activity (ISRA)

Scientific Indexing Services (SIS)

Polish Scholarly Bibliography

Global Impact Factor (GIF) (Under Process)

Universal Impact Factor

International Scientific Indexing (ISI), UAE

Index Copernicus

CAS (A Division of American Chemical Society) USA (Under Process)

Directory of Open Access Journal (DOAJ, Sweden, in process)

UDLedge Science Citation Index

CiteFactor

Directory Of Research Journal Indexing (DRJI)

Indian citation Index (ICI)

Journal Index (JI, Under Process)

Directory of abstract indexing for Journals (DAIJ)

Open Access Journals (Under Process)

Impact Factor Services For International Journals (IFSIJ)

Cosmos Impact Factor

Jour Informatics (Under Process)

Eurasian Scientific Journal Index (ESJI)

International Innovative Journal Impact Factor (IIJIF)

Science Library Index, Dubai, United Arab Emirates

Pubmed Database [NLM ID: 101669306] (Under Process)

IP Indexing (IP Value 2.40)

Web of Science Group (Under Process)

Directory of Research Journals Indexing

Scholar Article Journal Index (SAJI)

International Scientific Indexing ( ISI )

Scope Database

Academia

Doi-Digital Online Identifier

ISSN National Centre

Zenodo Indexing

International CODEN Service, USA